|
TECH | Bio-Techne Corp |
|
|
TECH | Bio-Techne Corp |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 0.60 |
| Leverage | 22.67% |
| Market Cap | $ 10.4B |
| PE | 78.97 |
| Dividend Yield | 0.47% |
| Profit | $ 131.3m |
| Margin | 10.87% |
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.